EVELYN KUANG: Open Payments
NPI 1588188700 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 19 payments from 7 companies in 2025. Trend: 2023 $2,259 · 2024 $1,535 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $204 |
| ABBVIE INC. | 4 | $107 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Lundbeck LLC | 1 | $28 |
| Alkermes, Inc. | 1 | $20 |
Products named: COBENFY, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, UZEDY, LYBALVI.
Industry payments across NY — which companies pay providers there.
